Rheumatology
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management.
28 Jul, 2021 | 09:44h | UTC
The use and impact of monoclonal antibody biologics during pregnancy.
28 Jul, 2021 | 09:43h | UTC
RCT: Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders.
22 Jul, 2021 | 10:42h | UTCCommentaries: Optimising treatment for patients with rotator cuff disorders – The Lancet (free registration required)
Commentary on Twitter (thread – click for more)
The much-anticipated GRASP trial for rotator cuff pain has just been published showing steroid injections have a small short-lasting benefit, and that physio led exercise was no better than patient led exercise… Here's my short Twitter review… 1/12 https://t.co/1TFYGoAi7X
— The Sp⚽️rts Physio (@AdamMeakins) July 13, 2021
Sacroiliac joint dysfunction: pathophysiology, diagnosis, and treatment.
21 Jul, 2021 | 10:26h | UTCSacroiliac joint dysfunction: pathophysiology, diagnosis, and treatment – European Spine Journal
Sarcoidosis: A clinical overview from symptoms to diagnosis.
15 Jul, 2021 | 08:58h | UTCSarcoidosis: A Clinical Overview from Symptoms to Diagnosis – Cells
2021 ACR Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
13 Jul, 2021 | 09:41h | UTC
2021 ACR Guideline for the Management of Polyarteritis Nodosa.
13 Jul, 2021 | 09:37h | UTC
2021 ACR Guideline for the Management of ANCA–Associated Vasculitis.
9 Jul, 2021 | 10:09h | UTC
M-A: Little benefit from muscle relaxants for adults with non-specific low back pain.
9 Jul, 2021 | 10:02h | UTCCommentary: New analysis finds muscle relaxant drugs to be largely ineffective for low back pain – News Medical
Related studies: M-A: Effectiveness of treatments for acute and subacute mechanical non-specific low back pain AND RCT: Little benefit from osteopathic manipulative treatment on activity limitations in patients with nonspecific subacute and chronic low back pain AND M-A: Little benefit from antidepressants for low back pain AND Meta-analysis: Little benefit from antidepressants for the treatment of back pain and osteoarthritis AND ACP/AAFP Guideline: Nonpharmacologic and pharmacologic management of acute pain from non–low back, musculoskeletal injuries in adults
Commentaries on Twitter
Muscle relaxants are largely ineffective for #lowback #pain. They might increase the risk of side effects.
Published today in @bmj_latest ⬇️
Proud to be a part of this excellent team led by @AidanCashin
Paper: https://t.co/4p7gd7PJIe pic.twitter.com/3CLvL7JUfI
— Hayley Leake (@HayleyLeake) July 8, 2021
This systematic review found very low certainty evidence that muscle relaxant drugs for the treatment of acute low back pain might provide a small and not clinically meaningful improvement in pain intensity at two weeks or less @Pain_NeuRa https://t.co/HGwN4Oekrq
— The BMJ (@bmj_latest) July 8, 2021
Adult-Onset Still’s Disease: Clinical Aspects and Therapeutic Approach.
9 Jul, 2021 | 09:47h | UTC
Guideline | Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring.
6 Jul, 2021 | 10:03h | UTCExecutive summary: Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring – Royal College of Ophthalmologists
M-A: The efficacy of systemic glucocorticosteroids for pain in rheumatoid arthritis.
6 Jul, 2021 | 09:54h | UTC
Consensus-based recommendations for the management of juvenile systemic sclerosis
2 Jul, 2021 | 11:08h | UTCConsensus-based recommendations for the management of juvenile systemic sclerosis – Rheumatology
Case report: Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.
22 Jun, 2021 | 10:04h | UTC
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
10 Jun, 2021 | 09:37h | UTCCommentary: The 2021 Treatment Guidelines for Rheumatoid Arthritis – Rheumatology Network
M-A: Effectiveness of telerehabilitation in physical therapist practice.
10 Jun, 2021 | 09:29h | UTC
ANCA-Associated Vasculitis: An Update.
4 Jun, 2021 | 10:23h | UTCANCA-Associated Vasculitis: An Update – Journal of Clinical Medicine
RCT: Among patients with ANCA-associated vasculitis without severe glomerulonephritis or alveolar hemorrhage treated with Rituximab, a reduced-dose glucocorticoids regimen (prednisolone 0.5 mg/kg/d) was noninferior to a high-dose glucocorticoid regimen (prednisolone 1 mg/kg/d) for the induction of disease remission.
4 Jun, 2021 | 10:25h | UTC
Podcast | Osteoporosis in Primary Care.
1 Jun, 2021 | 08:06h | UTC#277 Bone Up on Osteoporosis in Primary Care with Dr. Carolyn Crandall – The Curbsiders
EULAR recommendations for intra-articular therapies.
28 May, 2021 | 08:16h | UTCEULAR recommendations for intra-articular therapies – Annals of Rheumatic Diseases
Methotrexate reduces immune response to mRNA COVID-19 vaccine in patients with immune-mediated inflammatory disease.
26 May, 2021 | 08:38h | UTCCommentary: Methotrexate users have a reduced immune response to mRNA COVID-19 vaccine – BMJ
Large cohort study confirms the renal toxicities of anti-inflammatories, suggesting Ibuprofen may be the safest option among them.
19 May, 2021 | 08:28h | UTCComparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD – Clinical Journal of the American Society of Nephrology (link to abstract – $ for full-text)
Commentary: Study: Ibuprofen Found Safest NSAID for the Kidney – MPR
Commentary on Twitter
Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD
Read this new @CJASN study and listen to the accompanying podcast:https://t.co/GL1ITzh4O4 pic.twitter.com/lZGeFqfrDZ
— Am Soc Nephrology (@ASNKidney) April 29, 2021
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
13 May, 2021 | 05:49h | UTCCommentary: EULAR issues recommendations on self-management strategies for inflammatory arthritis – MedwireNews
Editorial | “Peeling off musculoskeletal labels: sticks and stones may break my bones, but diagnostic labels can hamstring me forever”
11 May, 2021 | 08:59h | UTC
Commentary on Twitter
Grateful to share our new @BJSM_BMJ editorial @KarimKhan_IMHA @DrLouiseTulloh
Peeling off musculoskeletal labels: sticks and stones may break my bones, but diagnostic labels can hamstring me forever
?? https://t.co/5LAEUNK6d2#PreventingOverdiagnosis #TooMuchMedicine pic.twitter.com/ZD0CyxmGHp
— Daniel Friedman (@ddfriedman) May 6, 2021
RCT: Efficacy and safety of voclosporin for lupus nephritis – voclosporin + MMF + low dose corticosteroids achieved complete renal response at week 52 more often than MMF + low dose corticosteroids alone (41% vs. 23%).
10 May, 2021 | 00:48h | UTCEfficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)